| Bisoprolol Viatris 2.5 mg film-coated tablets PA23266/055/002 |
BISOPROLOL FUMARATE |
Viatris Limited |
Marketed |
| Bisoprolol Viatris 3.75 mg film-coated tablets PA23266/055/003 |
BISOPROLOL FUMARATE |
Viatris Limited |
Not marketed |
| Bisoprolol Viatris 5 mg film-coated tablets PA23266/055/004 |
BISOPROLOL FUMARATE |
Viatris Limited |
Marketed |
| Bisoprolol Viatris 7.5 mg film-coated tablets PA23266/055/005 |
BISOPROLOL FUMARATE |
Viatris Limited |
Marketed |
| Bisoprolol Zentiva 1.25mg tablets PA1701/010/001 |
BISOPROLOL FUMARATE |
Zentiva k.s. |
Marketed |
| Bisoprolol Zentiva 10 mg tablets PA1701/010/006 |
BISOPROLOL FUMARATE |
Zentiva k.s. |
Marketed |
| Bisoprolol Zentiva 2.5mg tablets PA1701/010/002 |
BISOPROLOL FUMARATE |
Zentiva k.s. |
Marketed |
| Bisoprolol Zentiva 3.75mg tablets PA1701/010/003 |
BISOPROLOL FUMARATE |
Zentiva k.s. |
Marketed |
| Bisoprolol Zentiva 5mg tablets PA1701/010/004 |
BISOPROLOL FUMARATE |
Zentiva k.s. |
Marketed |
| Bisoprolol Zentiva 7.5mg tablets PA1701/010/005 |
BISOPROLOL FUMARATE |
Zentiva k.s. |
Marketed |
| Bisoprololhemifumaraat Genthon 10 mg, film-coated tablets PA0740/007/002 |
Bisoprolol hemifumarate |
Genthon B.V. |
Not marketed |
| Bisoprololhemifumaraat Genthon 5 mg film-coated tablets PA0740/007/001 |
Bisoprolol hemifumarate |
Genthon B.V. |
Not marketed |
| Bitifrin 0.3 mg/ml + 5 mg/ml eye drops, solution PA1391/005/001 |
Bimatoprost, Timolol Maleate |
Farmaprojects S.A.U |
Not marketed |
| BLENREP 100 mg powder for concentrate for solution for infusion EU/1/25/1948/002 |
Belantamab Mafodotin |
GlaxoSmithKline Trading Services Limited |
— |
| BLENREP 70 mg powder for concentrate for solution for infusion EU/1/25/1948/001 |
Belantamab Mafodotin |
GlaxoSmithKline Trading Services Limited |
— |
| BLINCYTO 38.5 micrograms powder for concentrate and solution for solution for infusion EU/1/15/1047/001 |
Blinatumomab |
Amgen Europe B.V., |
— |
| Blissel 50 micrograms/g vaginal gel PA2102/001/001 |
Estriol |
Italfarmaco S.A. |
Not marketed |
| Blitzima 100 mg concentrate for solution for infusion EU/1/17/1205/001-002 |
Rituximab |
Celltrion Healthcare Hungary Kft. |
— |
| Blopress 16 mg Tablets PA2239/014/004 |
Candesartan cilexetil |
CHEPLAPHARM Arzneimittel GmbH |
Not marketed |
| Blopress 32 mg Tablets PA2239/014/005 |
Candesartan cilexetil |
CHEPLAPHARM Arzneimittel GmbH |
Not marketed |
| Blopress 4 mg Tablets PA2239/014/002 |
Candesartan cilexetil |
CHEPLAPHARM Arzneimittel GmbH |
Not marketed |
| Blopress 8 mg Tablets PA2239/014/003 |
Candesartan cilexetil |
CHEPLAPHARM Arzneimittel GmbH |
Not marketed |
| Blopress Plus 16 mg/12.5 mg tablets PA2239/015/002 |
Candesartan cilexetil, Hydrochlorothiazide |
CHEPLAPHARM Arzneimittel GmbH |
Not marketed |
| Blopress Plus 32 mg/12.5 mg tablets PA2239/015/003 |
Candesartan cilexetil, Hydrochlorothiazide |
CHEPLAPHARM Arzneimittel GmbH |
Not marketed |
| Blopress Plus 32 mg/25 mg tablets PA2239/015/004 |
Candesartan cilexetil, Hydrochlorothiazide |
CHEPLAPHARM Arzneimittel GmbH |
Not marketed |
| Blopress Plus 8 mg/12.5 mg tablets PA2239/015/001 |
Candesartan cilexetil, Hydrochlorothiazide |
CHEPLAPHARM Arzneimittel GmbH |
Not marketed |
| BOCOUTURE 100 units powder for solution for injection PA1907/003/002 |
CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS |
Merz Pharmaceuticals GmbH |
Marketed |
| BOCOUTURE 50 units powder for solution for injection PA1907/003/001 |
CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS |
Merz Pharmaceuticals GmbH |
Marketed |
| BOMYNTRA 120 mg solution for injection in pre-filled syringe EU/1/25/1953/04-06 |
Denosumab |
Fresenius Kabi Deutschland GmbH |
— |
| BOMYNTRA 120 mg solution for injection in vial EU/1/25/1953/01-03 |
Denosumab |
Fresenius Kabi Deutschland GmbH |
— |
| Bonasol Once Weekly 70 mg Oral Solution PA1572/001/001 |
Alendronate sodium trihydrate |
Xeolas Pharmaceuticals Limited |
Marketed |
| Bondronat 2 mg concentrate for solution for infusion. EU/1/96/012/004 |
Ibandronic acid monosodium monohydrate |
Atnahs Pharma Netherlands B.V. |
— |
| Bondronat 50 mg film-coated tablets EU/1/96/012/009-010 |
Ibandronic acid |
Atnahs Pharma Netherlands B.V. |
— |
| Bondronat 6 mg concentrate for solution for infusion EU/1/96/012/011-13 |
Ibandronic acid |
Atnahs Pharma Netherlands B.V. |
— |
| Bonjela Oromucosal Gel Choline Salicylate 8.714% Cetalkonium Chloride 0.010% PA0979/001/001 |
Choline salicylate, Cetalkonium chloride |
Reckitt Benckiser Ireland Limited |
Marketed |
| Bonjela Teething Gel Oromucosal Gel Choline Salicylate 8.714% Cetalkonium Chloride 0.010% PA0979/001/003 |
Choline salicylate, Cetalkonium chloride |
Reckitt Benckiser Ireland Limited |
Marketed |
| Bonviva 150 mg film-coated tablets EU/1/03/265/3-4 |
Ibandronic acid |
Atnahs Pharma Netherlands B.V. |
— |
| Bonviva 3 mg solution for injection EU/1/03/265/5-6 |
Ibandronic acid |
Atnahs Pharma Netherlands B.V. |
— |
| Boostrix suspension for injection in pre-filled syringe Diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed, reduced antigen(s) content) PA1077/020/001 |
Pertactin, Filamentous haemagglutinin, Pertussis toxoid, Tetanus toxoid, Diphtheria toxoid |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Bortezomib 1 mg powder for solution for injection PA23142/012/001 |
Bortezomib |
Aspire Pharma (Malta) Limited |
Not marketed |
| Bortezomib 2.5 mg powder for solution for injection PA23142/012/003 |
Bortezomib |
Aspire Pharma (Malta) Limited |
Not marketed |
| Bortezomib 2.5 mg/ml solution for injection PA1774/008/001 |
Bortezomib |
EVER Valinject GmbH |
Marketed |
| Bortezomib 3.5 mg powder for solution for injection PA23142/012/002 |
Bortezomib |
Aspire Pharma (Malta) Limited |
Not marketed |
| Bortezomib 3.5 mg powder for solution for injection PA23092/003/001 |
Bortezomib |
Reddy Holding GmbH |
— |
| Bortezomib 3.5 mg powder for solution for injection PA23250/003/001 |
Bortezomib |
MSN Labs Europe Limited |
Marketed |
| Bortezomib Accord 1 mg Powder for solution for injection EU/1/15/1019/002 |
Bortezomib |
Accord Healthcare S.L.U. |
— |
| Bortezomib Accord 2.5 mg/ml Solution for injection EU/1/15/1019/003-006 |
Bortezomib |
Accord Healthcare S.L.U. |
— |
| Bortezomib Accord 3.5 mg Powder for solution for injection EU/1/15/1019/001 |
Bortezomib |
Accord Healthcare S.L.U. |
— |
| Bortezomib Biotech Pharma 3.5 mg powder for solution for injection PA25233/001/001 |
Bortezomib |
Target Healthcare Limited |
Not marketed |
| Bortezomib Clonmel 2.5 mg/ml Solution for Injection PA0126/297/001 |
Bortezomib |
Clonmel Healthcare Ltd |
Marketed |